YOU SEARCHED BY...
SEARCH BY...
Contract Service Directory
Country
- Argentina(1)
- Australia(8)
- Austria(1)
- Belgium(3)
- Canada(59)
- China(20)
- Denmark(2)
- Estonia(2)
- Finland(1)
- France(13)
- Germany(41)
- Greece(2)
- Hong Kong(1)
- Hungary(3)
- India(76)
- Ireland(1)
- Israel(3)
- Italia (6)
- Japan(2)
- Latvia(1)
- Lithuania(1)
- Mexico(2)
- New Zealand(1)
- Peru(1)
- Poland(2)
- Portugal(3)
- Romania(1)
- Singapore(1)
- Slovenia(2)
- South Korea(6)
- Spain(15)
- Sweden(3)
- Switzerland(22)
- Taiwan(3)
- The Czech Republic(1)
- The Netherlands(5)
- Turkey(2)
- Ukraine(2)
- United Kingdom(51)
- United States(680)
- Vietnam(1)
Contract Service Directory
MPI Research
Company Headquarters
54943 North Main Street
Mattawan, MI 49071
United States
Contract Service Directory
- ADMET
- Analytical Laboratory Services
- Analytical Methods Development
- Analytical Validation Studies
- Assay Development
- Bioanalytical Analysis LC/MS/MS
- Bioanalytical Services
- Bioavailability Studies
- Biological Testing
- Biologics Process Development
- Biomarker Research & Validation
- Biometrics
- Biosimilars
- Chemical Analysis
- Chemicals and Raw Materials
More Content From MPI Research
-
Six Crucial Steps For Establishing Humane Endpoints Before You Start Your Preclinical Safety Study
Why are humane endpoints diffi cult to develop?White Papers / Tech Papers Released on 08.17.2015
-
Recent issues in bioanalysis
A full immersion in bioanalysis (Part 1 – small molecules by LCMS)White Papers / Tech Papers Released on 07.27.2015
-
Recent issues in bioanalysis
A full immersion in bioanalysis (Part 2 – hybrid LBA/LCMS, ELN & regulatory agencies’ input)White Papers / Tech Papers Released on 07.26.2015
-
Recent issues in bioanalysis
A full immersion in bioanalysis (Part 3 – LBA and immunogenicity)White Papers / Tech Papers Released on 07.25.2015
-
MPI Research Hires Scientific Director of Pathology
MPI Research announced today that James F. Reindel, DVM, PhD, DACVP has been appointed Scientific Director of Pathology.News Releases Released on 07.16.2015
-
MPI Research Grows Ophthalmology Services with Director Addition
Dr. Josh Bartoe to lead expansion of ophthalmology specializationNews Releases Released on 07.08.2015
-
Multivariate Study Design Using Short - and Long-lived Radioisotopes
...Literature / Brochures Released on 05.13.2015
-
How Companies Can Make the Most of Their Early Drug Development Stage
Dean Knuth, Executive Director of Clinical SciencesLiterature / Brochures Released on 05.12.2015
-
Partnering with CROs
Q&A with Ed Amat, Executive Vice President of Global Sales & Marketing, MPI ResearchLiterature / Brochures Released on 05.11.2015
-
Dermal Toxicology: A Multifaceted Approach To Meet Today’s Research Needs
Lisa Craig, BS; Chris Papagiannis, BS; and Duane Poage, MSLiterature / Brochures Released on 12.31.2014
-
MPI Research Acquires Jasper Clinical Research & Development
Addition of Respected Clinical Trials Company Expands MPI Research Capabilities to Include Human Phase I TestingNews Releases Released on 10.27.2014
-
Translational Imaging Center Grand Opening Marks New Era in Drug Development
One-of-a-kind facility cost-effectively accelerates discovery and development timelineNews Releases Released on 05.09.2014
-
Cyclotron Arrival at Translational Imaging Center Announced by CRO Partnership
Particle accelerator will produce radioisotopes for tagging and tracking potential new drugs starting this springNews Releases Released on 02.06.2014
Related Content
-
Breaking News | Industry News
Melinta Buys Infectious Disease Unit from The Medicines Company
The deal is worth well over $200M, not including future milestones and royalties11.29.17
-
Collaborations & Alliances | Industry News
Pertinax Pharma Appoints New Chairman
Nigel Brooksby brings nearly 40 years experience, and was formerly the chairman of Sanofi11.21.17
-
Breaking News | Cytotoxics and High Potency Manufacturing | Facilities | Industry News
PCI Expands Highly Potent Capabilities for Clinical Services
Makes another investment in fully contained Xcelodose 600S technology11.10.17
-
Laboratory Testing
Sterigenics Int’l Changes Name to Sotera Health LLC
Operating companies Nelson Labs, Nordion and Sterigenics, will maintain their names11.08.17
-
cGMP Manufacture | Information Technology
Flexible Manufacturing Strategies and Data Integrity
Making processes integral with your data handling abilityEmil W. Ciurczak, DoraMaxx Consulting 11.07.17
-
Industry News | Packaging & Tracking | Serialization
-
Financial Reports
-
Drug Development | Industry News
CPhI Report Addresses Battle Between Innovators and Biogenerics
Regulation shifting due to increased data dependence, regulatory oversight is slowing six sigma, forecasts generic growth10.24.17
-
Aseptic Processing | Injectables
Sterile Manufacturing: Future Trends and Challenges
By the middle of this century, biopharmaceuticals are set to overtake all other pharma salesIgor Gorsky, Concordia Valsource 10.11.17
-
Bio News | Bioanalytical Services | Breaking News | Drug Discovery | Industry News | Preclinical Outsourcing
ABL Acquisition Extends Ardena’s Early-phase Offering
Broadens the CDMO’s pre-clinical and clinical offering to include bioanalytical and drug discovery services.10.10.17
-
cGMP Manufacture | Drug Development | Regulatory Affairs
Contracting & Outsourcing Session Highlights and Key Takeaways
Insight into CMO Trends, Biotrends, Manufacturing Compliance, FDA Quality Agreements, and CMO OversightKristin Brooks, Contract Pharma 10.09.17
-
Industry News
Sterigenics, Noxilizer Ink NO2 Sterilization Pact
Sterigenics to serve as exclusive worldwide provider of nitrogen dioxide contract sterilization services10.03.17
-
Biosimilars
Know the Challenges of Biosimilar Manufacturing
Best practices for a competitive marketJerry Martin and Michiel Ultee 09.06.17
-
Clinical Trials | Drug Development
Cancer Trials in the New Age of Drug Development
Insights into the rapid pace of new drug approvals and the implications for pharma/biopharma companies08.21.17
-
Breaking News | cGMP Manufacture | Industry News
FDA Reauthorization Act Signed into Law
Renews four major user fee agreements between industry and FDA through FY202208.21.17
-
Breaking News | Industry News | QA/QC
QPharma Expands Footprint with Somerset-area Office
New central location will enhance solutions and services08.18.17
-
Industry News | Inspections
Valeant's Tampa Facility Receives FDA VAI Classification
Following collaboration with FDA, issues related to a cGMP inspection are being resolved08.17.17
-
Breaking News | cGMP Manufacture | Drug Development | Industry News | Regulatory Affairs
Senate Passes FDA Reauthorization Act
Aims to allow faster approval of generic drugs and modifies fee structure for various stakeholders08.04.17
-
Analytical Services | Breaking News | Industry News | Laboratory Testing
Whitehouse Labs Expands Testing Capabilities
Expansion of drug delivery device testing capabilities to encompass the full series of ISO 80369 standard test procedures07.17.17
